ORCID as entered in ROS

Select Publications
2011, 'RE-INCARCERATION FOLLOWING PRISON-BASED OPIOID SUBSTITUTION TREATMENT', DRUG AND ALCOHOL REVIEW, 30, pp. 52 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Evaluating health outcomes of criminal justice populations using record linkage: the importance of aliases', Evaluation Review, 35, pp. 118 - 128, http://erx.sagepub.com/content/35/2/118
,2011, 'Health outcomes, program completion, and criminal recidivism among participants in the Rural Alcohol Diversion program, Australia', Journal of Substance Use, 16, pp. 50 - 56, http://dx.doi.org/10.3109/14659891003706407
,2010, '"OPENING DOORS": INCREASING ACCESS TO AND PARTICIPATION IN YOUTH FRIENDLY HARM REDUCTION IN KATHMANDU, BANGKOK AND KUNMING', DRUG AND ALCOHOL REVIEW, 29, pp. 35 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'An estimate of the number of inmate separations from Australian prisons 2000/01 and 2005/06', Australian and New Zealand Journal of Public Health, 34, pp. 255 - 257
,2010, 'Compulsory detoxification is a major challenge to harm reduction in China', International Journal of Drug Policy, 21, pp. 165 - 166, http://dx.doi.org/10.1016/j.drugpo.2009.05.001
,2010, 'Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviour? A systematic review', Addiction, 105, pp. 216 - 223, http://dx.doi.org/10.1111/j.1360-0443.2009.02826.x
,2010, 'Factors affecting criminal recidivism among participants in the Magistrates Early Referral into Treatment (MERIT) program in New South Wales, Australia', Drug and Alcohol Review, 29, pp. 684 - 688, http://dx.doi.org/10.1111/j.1465-3362.2010.00186.x
,2010, 'HIV in Indian prisons: Risk behaviour, prevalence, prevention and treatment', Indian Journal of Medical Research, 132, pp. 696 - 700
,2009, 'A literature review of international implementation of opioid subsitution treatment in prisons: Equivalence of care?', European Addiction Research, 15, pp. 107 - 112
,2009, 'A review of HIV in prisons in Nepal', Kathmandu University Medical Journal, 7, pp. 351 - 354, http://www.kumi.com.np/
,2009, 'Factors associated with violent victimisation among homeless adults in Sydney, Australia', Australian and New Zealand Journal of Public Health, 33, pp. 347 - 351, http://dx.doi.org/10.1111/j.1753-6405.2009.00406.x
,2009, 'Inadequate data collection prevents health planing for released prisoners', Medical Journal of Australia, 191, pp. 408 - 409, http://dx.doi.org/10.5694/j.1326-5377.2009.tb02854.x
,2009, 'Presence of hepatitis C virus in syringes confiscated in prisons in Australia', Journal of Gastroenterology and Hepatology, 24, pp. 1655 - 1657
,2008, 'An exploratory study of needlestick injuries among Australian prison officers', International Journal of Prisoner Health, 4, pp. 164 - 168
,2008, 'Increased access to opioid substitution treatment in prisons is needed to ensure equivalence of care', Australian and New Zealand Journal of Public Health, 32, pp. 86 - 87, http://dx.doi.org/10.1111/j.1753-6405.2008.00172.x
,2008, 'Residential detoxification: essential for marginalised, severely alcohol- and drug-dependent individuals', Drug and Alcohol Review, 27, pp. 414 - 419
,2007, 'The integration of harm reduction into abstinence-based therapeutic communities: A case study of We Help Ourselves.', ASIAN JOURNAL OF COUNSELLING, 14, pp. 1 - 19
,'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International journal of population data science, 7
,2023, 'A proposal for a best-evidence model of care and program logic for supported accommodation for people released from prison', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S77 - S78
,2023, 'Association of opioid analgesics, benzodiazepines, gabapentinoids and opioid agonist treatment with mortality among individuals with opioid dependence', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S40 - S41
,2023, 'The risk of fatal opioid overdose associated with the concurrent use of opioid analgesics and psychotropic medicines: A retrospective population-based cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 589 - 590
,2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000859084401349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'THE EFFECT OF PERSON, TREATMENT AND PRESCRIBER CHARACTERISTICS ON RETENTION IN OPIOID AGONIST TREATMENT: A 15-YEAR RETROSPECTIVE COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S46 - S47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'THE EXPERIENCE OF BEING RELEASED FROM JAIL: A CASE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S73 - S74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'The epidemiology of all-cause and cause-specific mortality following release from prison in 11 countries', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000983532000002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'POPPY II cohort profile- a population-based linked cohort examining the course and outcomes of prescription opioid use in NSW, Australia, 2003-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 300 - 301, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300611&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'DOES NALOXONE PROVISION LEAD TO INCREASED SUBSTANCE USE? A SYSTEMATIC REVIEW TO ASSESS IF THERE IS EVIDENCE OF A 'MORAL HAZARD' ASSOCIATED WITH NALOXONE SUPPLY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S145 - S145
,2021, 'THE INCIDENCE OF INJECTING-RELATED DISEASES AMONG PEOPLE PRESCRIBED OPIOID AGONIST TREATMENT IN NEW SOUTH WALES: A RETROSPECTIVE DATA LINKAGE STUDY USING HOSPITAL ADMINISTRATION DATA', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S58 - S58
,2017, 'Injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting, 2005-2014: the HITS-p study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S488 - S488, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31370-3
,2016, 'EPIDEMIOLOGICAL DEFINITIONS AND ESTIMATES OF POPULATIONS OF PEOPLE WHO INJECT DRUGS WITH HEPATITIS C VIRUS INFECTION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 14 - 15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'SUSTAINED-RELEASE PREPARATIONS OF NALTREXONE FOR THE TREATMENT OF ALCOHOL AND OPIOID DEPENDENCE: CURRENT STATUS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 40 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Prescription Opioid Access Patterns in Australia: A National Observational Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 216 - 217, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483502006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'COMMUNITY PHARMACY AS A PARTNER IN NALOXONE SUPPLY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 10 - 11
,2014, 'HARM PRODUCTION AND HARM REDUCTION IN PRISONS AND POST-RELEASE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 64 - 65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800185&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'MORTALITY AMONG OLDER ADULTS WITH OPIOID USE DISORDERS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 40 - 40, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'LIVER-RELATED MORTALITY AMONG OPIOID-DEPENDENT PEOPLE IN NEW SOUTH WALES, 1985-2005', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 26 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'ILLICIT DRUG USE AND OPIOID SUBSTITUTION TREATMENT AMONG NSW PRISONERS: FINDINGS FROM THREE WAVES OF THE INMATE HEALTH SURVEY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 52 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Vol. 26, pp. 106 - 106, presented at National Drug and Alcohol Research Centre 2017 Annual Symposium, 03 October 2017 - 04 October 2017
,2013, 'Opioid substitution therapy in New South Wales 2001-2012: Comparison between buprenorphine and methadone users', Vol. 146, pp. e234 - e235, presented at National Drug and Alcohol Research Centre 2013 Annual Symposium, 04 September 2013 - 04 September 2013, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.105
,2024, 'Development of opioid use disorder following treatment with opioid analgesics for non-cancer pain relief: an Australian state-wide nested case-control study', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=SwVO9ONBuE8&t=5295s
,2024, 'Population ageing and apparent decline in initiation of injecting drug use in Australia', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=762s
,2023, 'Association of Opioid Analgesics, Benzodiazepines, Gabapentinoids, and Opioid Agonist Treatment With Mortality Among Individuals With Opioid Dependence', in DRUG AND ALCOHOL DEPENDENCE, ELSEVIER IRELAND LTD, CO, Denver, Vol. 260, presented at 85th Annual Scientific Meeting of the College-on-Problems-of-Drug-Dependence (CPDD), CO, Denver, 17 July 2023 - 21 July 2023, http://dx.doi.org/10.1016/j.drugalcdep.2023.110845
,2021, 'INCIDENCE OF FATAL AND NON-FATAL DRUG OVERDOSE AMONG PEOPLE WITH A HISTORY OF OPIOID DEPENDENCE INCREASE IN THE FIRST FOUR WEEKS OF TREATMENT CESSATION: RETROSPECTIVE LINKAGE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S87 - S87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'The effect of prescriber, treatment, and client characteristics on retention in opioid agonist treatment: A 15-year retrospective cohort study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 357 - 357, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300726&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'HEPATITIS C VIRUS CASCADE OF CARE AMONG PEOPLE WHO INJECT DRUGS: A CROSS-SECTIONAL STUDY OF CHARACTERISTICS ASSOCIATED WITH HCV TESTING AND TREATMENT IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S48 - S48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'ILLICIT DRUG USE IN AUSTRALIAN PRISONS AMONGST PEOPLE WHO REGULARLY INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S48 - S48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'MORTALITY IN PEOPLE WHO USE OPIOIDS: SYSTEMATIC REVIEW AND META-ANALYSIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S99 - S99, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100250&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'MORTALITY IN PEOPLE WHO USE STIMULANTS: SYSTEMATIC REVIEW AND META-ANALYSIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S99 - S99, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100249&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'CHARACTERISING PEOPLE ATTENDING NEW SOUTH WALES EMERGENCY DEPARTMENTS AND HOSPITALS FOR AN ALCOHOL-RELATED PROBLEM, 2005-2014: THE DATA-LINKAGE ALCOHOL COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S81 - S82
,